|Listed in category:
Have one to sell?

FDA Regulatory Affairs 3rd Edition Hardback SPECIAL INDIAN EDITION

Last item available
Condition:
Like New
Offer ends in: 6d 6h
Last one / 2 sold
Price:
US $95.99
ApproximatelyEUR 88.78
Was US $119.99 What does this price mean?
Recent sales price provided by the seller
Save US $24.00 (20% off)
Postage:
Free Standard Shipping. See detailsfor postage
Located in: Ogden, Utah, United States
Delivery:
Estimated between Wed, 12 Jun and Sat, 15 Jun to 43230
Estimated delivery dates - opens in a new window or tab include seller's dispatch time, origin postcode, destination postcode and time of acceptance and will depend on delivery service selected and receipt of cleared paymentcleared payment - opens in a new window or tab. Delivery times may vary, especially during peak periods.
Returns:
30 days return. Seller pays for return postage. See details- for more information about returns
Payments:
    

Shop with confidence

eBay Money Back Guarantee
Get the item you ordered or your money back. 

Seller information

Registered as a business seller
Seller assumes all responsibility for this listing.
eBay item number:265361177781
Last updated on 29 Jan, 2024 20:42:53 GMTView all revisionsView all revisions

Item specifics

Condition
Like New: A book that has been read, but looks new. The book cover has no visible wear, and the dust ...
Brand
David Mantus, Douglas J. Pisano
Compatible Brand
David Mantus, Douglas J. Pisano
Color
Red
Model
NA
Manufacturer Part Number
NA
Compatible Model
NA
MPN
NA
Material
Paper
ISBN
9781841849195
Subject Area
Medical, Political Science
Publication Name
Fda Regulatory Affairs : Third Edition
Item Length
9.3 in
Publisher
Taylor & Francis Group
Subject
Clinical Medicine, Instruments & Supplies, General, Pharmacology, American Government / National
Publication Year
2014
Type
Textbook
Format
Hardcover
Language
English
Item Height
0.8 in
Author
Douglas J. Pisano
Item Width
6.3 in
Item Weight
24.4 Oz
Number of Pages
400 Pages

About this product

Product Information

FDA Regulatory Affairs is a roadmap to prescription drug, biologics, and medical device development in the United States. Written in plain English, the concise and jargon-free text demystifies the inner workings of the US Food and Drug Administration (FDA) and facilitates an understanding of how the agency operates with respect to compliance and product approval, including clinical trial exemptions, fast track status, advisory committee procedures, and more. The Third Edition of this highly successful publication: Examines the harmonization of the US Federal Food, Drug, and Cosmetic Act with international regulations on human drug, biologics and device development, research, manufacturing, and marketing Includes contributions from experts at organizations such as the FDA, National Institutes of Health (NIH), and PAREXEL Focuses on the new drug application (NDA) process, cGMPs, GCPs, quality system compliance, and corresponding documentation requirements Provides updates to the FDA Safety and Innovation Act (FDASIA), incorporating pediatric guidelines and follow-on biologics regulations from the 2012 Prescription Drug User Fee Act (PDUFA) V Explains current FDA inspection processes, enforcement options, and how to handle FDA meetings and required submissions Co-edited by an industry leader (Mantus) and a respected academic (Pisano), FDA Regulatory Affairs, Third Edition delivers a compilation of the selected US laws and regulations as well as a straightforward commentary on the FDA product approval process that's broadly useful to both business and academia.

Product Identifiers

Publisher
Taylor & Francis Group
ISBN-10
1841849197
ISBN-13
9781841849195
eBay Product ID (ePID)
159814175

Product Key Features

Author
Douglas J. Pisano
Publication Name
Fda Regulatory Affairs : Third Edition
Format
Hardcover
Language
English
Subject
Clinical Medicine, Instruments & Supplies, General, Pharmacology, American Government / National
Publication Year
2014
Type
Textbook
Subject Area
Medical, Political Science
Number of Pages
400 Pages

Dimensions

Item Length
9.3 in
Item Height
0.8 in
Item Width
6.3 in
Item Weight
24.4 Oz

Additional Product Features

Edition Number
3
Lc Classification Number
Rm301.25
Edition Description
Revised Edition,New Edition
Reviews
"This book covers the myriad of topics related to the development and marketing of all types of drugs and devices regulated by the U.S. Food and Drug Administration. The book discusses not only the relevant regulations, but also the administrative processes that sponsors must deal with in getting their products approved for marketing. ... This book covers many of the important issues in enough depth to answer basic questions related to the components of an IND (investigational new drug) and an NDA (new drug application), as well as IDE (investigational device exemption) and 510k applications. ... This book fulfills a unique need for those seeking a book for a course in drug and device development or for those in the industry who seek information outside of their area of expertise." --Michael R. Jacobs, BS, PharmD, Temple University School of Pharmacy, in Doody's Book Reviews, "This book covers the myriad of topics related to the development and marketing of all types of drugs and devices regulated by the U.S. Food and Drug Administration. The book discusses not only the relevant regulations, but also the administrative processes that sponsors must deal with in getting their products approved for marketing. ... This book covers many of the important issues in enough depth to answer basic questions related to the components of an IND (investigational new drug) and an NDA (new drug application), as well as IDE (investigational device exemption) and 510k applications. ... This book fulfills a unique need for those seeking a book for a course in drug and device development or for those in the industry who seek information outside of their area of expertise." --Michael R. Jacobs, BS, PharmD, Temple University School of Pharmacy, in Doody's Book Reviews
Table of Content
Overview of FDA and Drug Development. What Is an IND? The New Drug Application. Meetings with the FDA. FDA Medical Device Regulation. A Primer of Drug/Device Law: What Is the Law and How Do I Find It? The Development of Orphan Drugs. CMC Sections of Regulatory Filings and CMC Regulatory Compliance during Investigational and Postapproval Stages. Overview of the GxPs for the Regulatory Professional. FDA Regulation of the Advertising and Promotion of Prescription Drugs, Biologics, and Medical Devices. The Practice of Regulatory Affairs. FDA Advisory Committees. Biologics. Regulation of Combination Products in the United States.
Copyright Date
2014
Target Audience
Scholarly & Professional
Illustrated
Yes

Item description from the seller